As a pioneer in clinical regenerative medicine, Dr. Perin performed the first stem cell injection in a patient with heart failure in 2001 and subsequently published the first clinical trial to evaluate stem cell therapy in heart failure patients. As the founding Medical Director of the Stem Cell Center at THI in 1998, he has led multiple clinical trials of stem cell therapy, focusing on the treatment of heart failure, acute myocardial infarction, refractory angina, and peripheral arterial disease. Under his leadership, THI's Stem Cell Center has become recognized as a worldwide leader in clinical research in stem cell therapy. Moreover, Dr. Perin serves as a founding member and Principal Investigator in the NHLBI Cardiovascular Cell Therapy Research Network, which is a consortium of 7 sites funded by the National Heart, Blood, and Lung Institute and charged with advancing the use of cell therapy for treating heart disease.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.